Literature DB >> 28473466

Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors.

Cody A Desjardins1, Francisco J Naya2.   

Abstract

Cardiomyocytes acquire their primary specialized function (contraction) before exiting the cell cycle. In this regard, proliferation and differentiation must be precisely coordinated for proper cardiac morphogenesis. Here, we have investigated the complex transcriptional mechanisms employed by cardiomyocytes to coordinate antagonistic cell-cycle and differentiation gene programs through the molecular dissection of the core cardiac transcription factor, MEF2. Knockdown of individual MEF2 proteins, MEF2A, -C, and -D, in primary neonatal cardiomyocytes resulted in radically distinct and opposite effects on cellular homeostasis and gene regulation. MEF2A and MEF2D were absolutely required for cardiomyocyte survival, whereas MEF2C, despite its major role in cardiac morphogenesis and direct reprogramming, was dispensable for this process. Inhibition of MEF2A or -D also resulted in the activation of cell-cycle genes and down-regulation of markers of terminal differentiation. In striking contrast, the regulation of cell-cycle and differentiation gene programs by MEF2C was antagonistic to that of MEF2A and -D. Computational analysis of regulatory regions from MEF2 isoform-dependent gene sets identified the Notch and Hedgehog signaling pathways as key determinants in coordinating MEF2 isoform-specific control of antagonistic gene programs. These results reveal that mammalian MEF2 family members have distinct transcriptional functions in cardiomyocytes and suggest that these differences are critical for proper development and maturation of the heart. Analysis of MEF2 isoform-specific function in neonatal cardiomyocytes has yielded insight into an unexpected transcriptional regulatory mechanism by which these specialized cells utilize homologous members of a core cardiac transcription factor to coordinate cell-cycle and differentiation gene programs.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  antagonistic; cardiomyocyte; differentiation; gene regulation; transcription factor; transcriptomics

Mesh:

Substances:

Year:  2017        PMID: 28473466      PMCID: PMC5481567          DOI: 10.1074/jbc.M117.776153

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  How to make a heart: the origin and regulation of cardiac progenitor cells.

Authors:  Stéphane D Vincent; Margaret E Buckingham
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

2.  MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Authors:  Nelsa L Estrella; Amanda L Clark; Cody A Desjardins; Sarah E Nocco; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

Review 3.  Gene regulatory networks in the evolution and development of the heart.

Authors:  Eric N Olson
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

Review 4.  Molecular regulation of cardiomyocyte differentiation.

Authors:  Sharon L Paige; Karolina Plonowska; Adele Xu; Sean M Wu
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

5.  MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation.

Authors:  Nelsa L Estrella; Cody A Desjardins; Sarah E Nocco; Amanda L Clark; Yevgeniy Maksimenko; Francisco J Naya
Journal:  J Biol Chem       Date:  2014-11-21       Impact factor: 5.157

6.  Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation.

Authors:  Yaniv Hinits; Luyuan Pan; Charline Walker; John Dowd; Cecilia B Moens; Simon M Hughes
Journal:  Dev Biol       Date:  2012-06-28       Impact factor: 3.582

7.  The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.

Authors:  Yuri Kim; Dillon Phan; Eva van Rooij; Da-Zhi Wang; John McAnally; Xiaoxia Qi; James A Richardson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming.

Authors:  Cody A Desjardins; Francisco J Naya
Journal:  J Cardiovasc Dev Dis       Date:  2016-08-11

9.  The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.

Authors:  Eros Di Giorgio; Elisa Franforte; Sebastiano Cefalù; Sabrina Rossi; Angelo Paolo Dei Tos; Monica Brenca; Maurizio Polano; Roberta Maestro; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  PLoS Genet       Date:  2017-04-18       Impact factor: 5.917

10.  Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling.

Authors:  Stephanie Wales; Sara Hashemi; Alexandre Blais; John C McDermott
Journal:  Nucleic Acids Res       Date:  2014-09-12       Impact factor: 16.971

View more
  11 in total

Review 1.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

2.  The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart.

Authors:  Jose L Medrano; Francisco J Naya
Journal:  J Biol Chem       Date:  2017-10-20       Impact factor: 5.157

3.  Desmin deficiency affects the microenvironment of the cardiac side population and Sca1+ stem cell population of the adult heart and impairs their cardiomyogenic commitment.

Authors:  Sofia Nikouli; Mary Tsikitis; Christina Raftopoulou; Sarantis Gagos; Stelios Psarras; Yassemi Capetanaki
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 4.051

4.  MiR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D and modulating activities of Wnt/β-catenin signaling.

Authors:  Kai Li; Jin Pan; Jianjun Wang; Fengrui Liu; Li Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 5.  Regulation of cardiomyocyte maturation during critical perinatal window.

Authors:  Suraj Kannan; Chulan Kwon
Journal:  J Physiol       Date:  2019-01-15       Impact factor: 6.228

6.  Diet-MEF2 interactions shape lipid droplet diversification in muscle to influence Drosophila lifespan.

Authors:  Xiao Zhao; Xiaotong Li; Xiangyu Shi; Jason Karpac
Journal:  Aging Cell       Date:  2020-06-14       Impact factor: 9.304

7.  Drosophila mef2 is essential for normal mushroom body and wing development.

Authors:  Jill R Crittenden; Efthimios M C Skoulakis; Elliott S Goldstein; Ronald L Davis
Journal:  Biol Open       Date:  2018-09-07       Impact factor: 2.422

8.  Chromatin Environment and Cellular Context Specify Compensatory Activity of Paralogous MEF2 Transcription Factors.

Authors:  Shahriyar P Majidi; Naveen C Reddy; Michael J Moore; Hao Chen; Tomoko Yamada; Milena M Andzelm; Timothy J Cherry; Linda S Hu; Michael E Greenberg; Azad Bonni
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

9.  MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure.

Authors:  Ana Helena M Pereira; Alisson C Cardoso; Silvio R Consonni; Renata R Oliveira; Angela Saito; Maria Luisa B Vaggione; Jose R Matos-Souza; Marcelo F Carazzolle; Anderson Gonçalves; Juliano L Fernandes; Gustavo C A Ribeiro; Mauricio M Lopes; Jeffery D Molkentin; Kleber G Franchini
Journal:  EBioMedicine       Date:  2020-01-03       Impact factor: 8.143

10.  A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Lanette M Christensen; Tatiana Akimova; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Claudio Brancolini; Ulf H Beier; Wayne W Hancock
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.